Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

April 30, 2000

Conditions

HIV Infections

Interventions

DRUG

Tipranavir (TPV)

DRUG

Ritonavir (RTV)

DRUG

Delavirdine (DLV)

DRUG

Zidovudine (ZDV)

DRUG

Lamivudine (3TC)

DRUG

Stavudine (d4T)